Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 40% ± 20% | |
brain | 11 studies | 25% ± 10% | |
eye | 10 studies | 43% ± 23% | |
intestine | 9 studies | 41% ± 22% | |
kidney | 8 studies | 31% ± 12% | |
liver | 5 studies | 35% ± 13% | |
placenta | 4 studies | 36% ± 6% | |
uterus | 4 studies | 60% ± 12% | |
breast | 4 studies | 46% ± 6% | |
pancreas | 3 studies | 44% ± 30% | |
prostate | 3 studies | 42% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 25033.39 | 180 / 180 | 100% | 1355.63 | 430 / 430 |
liver | 100% | 29741.87 | 226 / 226 | 100% | 915.87 | 405 / 406 |
skin | 100% | 13051.38 | 1807 / 1809 | 100% | 653.05 | 470 / 472 |
prostate | 100% | 20420.11 | 244 / 245 | 100% | 1131.00 | 500 / 502 |
thymus | 100% | 12378.96 | 653 / 653 | 99% | 771.30 | 596 / 605 |
uterus | 100% | 32325.69 | 170 / 170 | 98% | 982.48 | 451 / 459 |
breast | 100% | 14041.43 | 459 / 459 | 97% | 802.05 | 1084 / 1118 |
kidney | 100% | 14729.47 | 89 / 89 | 96% | 497.51 | 865 / 901 |
lung | 100% | 17955.73 | 578 / 578 | 96% | 510.06 | 1105 / 1155 |
intestine | 99% | 20476.74 | 961 / 966 | 96% | 480.77 | 505 / 527 |
adrenal gland | 98% | 8745.90 | 254 / 258 | 97% | 809.90 | 222 / 230 |
esophagus | 100% | 20778.58 | 1445 / 1445 | 93% | 446.97 | 170 / 183 |
brain | 93% | 13834.51 | 2454 / 2642 | 100% | 912.06 | 705 / 705 |
bladder | 100% | 18890.19 | 21 / 21 | 91% | 554.17 | 460 / 504 |
stomach | 93% | 11049.24 | 334 / 359 | 92% | 414.34 | 263 / 286 |
pancreas | 62% | 2918.37 | 203 / 328 | 98% | 529.97 | 174 / 178 |
adipose | 100% | 14421.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 24429.99 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 634.03 | 44 / 45 |
heart | 96% | 7189.46 | 829 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 347.28 | 77 / 80 |
spleen | 96% | 6096.35 | 231 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 232.77 | 26 / 29 |
muscle | 44% | 1870.70 | 350 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 33% | 1689.29 | 307 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002376 | Biological process | immune system process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006260 | Biological process | DNA replication |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
Gene name | PTMS |
Protein name | Parathymosin PTMS protein |
Synonyms | hCG_25932 |
Description | FUNCTION: Parathymosin may mediate immune function by blocking the effect of prothymosin alpha which confers resistance to certain opportunistic infections. |
Accessions | A0A158RFU3 ENST00000309083.8 ENST00000710358.1 F5GXR3 ENST00000389462.8 A0AA34QVV1 P20962 A2VCM6 O15256 |